DK224785D0 - Konjugater, hvori en monovalent carboxylionophor ved hjaelp af en kovalent binding er knyttet til et makromolekyle, fremgangsmaade til fremstilling af konjugaterne og disses anvendelse som immunotoksinpotentiatorer - Google Patents

Konjugater, hvori en monovalent carboxylionophor ved hjaelp af en kovalent binding er knyttet til et makromolekyle, fremgangsmaade til fremstilling af konjugaterne og disses anvendelse som immunotoksinpotentiatorer

Info

Publication number
DK224785D0
DK224785D0 DK224785A DK224785A DK224785D0 DK 224785 D0 DK224785 D0 DK 224785D0 DK 224785 A DK224785 A DK 224785A DK 224785 A DK224785 A DK 224785A DK 224785 D0 DK224785 D0 DK 224785D0
Authority
DK
Denmark
Prior art keywords
conjugates
macromolecyle
immunotoins
carboxylion
horse
Prior art date
Application number
DK224785A
Other languages
English (en)
Other versions
DK164457C (da
DK224785A (da
DK164457B (da
Inventor
Franz Jansen
Pierre Gros
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8408073A external-priority patent/FR2564839B1/fr
Priority claimed from FR8411208A external-priority patent/FR2567521B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK224785D0 publication Critical patent/DK224785D0/da
Publication of DK224785A publication Critical patent/DK224785A/da
Publication of DK164457B publication Critical patent/DK164457B/da
Application granted granted Critical
Publication of DK164457C publication Critical patent/DK164457C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK224785A 1984-05-23 1985-05-21 Konjugater, hvor en monovalent carboxylionophor ved hjaelp af en kovalent binding er knyttet til et makromolekyle, fremgangsmaade til fremstilling af konjugaterne og disses anvendelse som immunotoksinpotentiatorer DK164457C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8408073A FR2564839B1 (fr) 1984-05-23 1984-05-23 Conjugues associant par liaison covalente un ionophore carboxylique monovalent et une macromolecule et leur utilisation comme agents potentialisateurs des immunotoxines
FR8408073 1984-05-23
FR8411208A FR2567521B1 (fr) 1984-07-13 1984-07-13 Nouveaux ionophores actives
FR8411208 1984-07-13

Publications (4)

Publication Number Publication Date
DK224785D0 true DK224785D0 (da) 1985-05-21
DK224785A DK224785A (da) 1985-11-24
DK164457B DK164457B (da) 1992-06-29
DK164457C DK164457C (da) 1992-11-16

Family

ID=26223983

Family Applications (1)

Application Number Title Priority Date Filing Date
DK224785A DK164457C (da) 1984-05-23 1985-05-21 Konjugater, hvor en monovalent carboxylionophor ved hjaelp af en kovalent binding er knyttet til et makromolekyle, fremgangsmaade til fremstilling af konjugaterne og disses anvendelse som immunotoksinpotentiatorer

Country Status (12)

Country Link
US (3) US4919928A (da)
EP (1) EP0162781B1 (da)
AU (1) AU600651B2 (da)
CA (1) CA1314245C (da)
DE (1) DE3571928D1 (da)
DK (1) DK164457C (da)
ES (1) ES8604228A1 (da)
GR (1) GR851229B (da)
IE (1) IE58480B1 (da)
IL (1) IL75228A (da)
NZ (1) NZ212118A (da)
PT (1) PT80501B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1314245C (en) * 1984-05-23 1993-03-09 Franz Jansen Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators
EP0313874B1 (en) * 1987-10-30 1994-04-13 American Cyanamid Company Disulfur analogs of LL-E33288 antitumor agents
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US5612034A (en) * 1990-10-03 1997-03-18 Redcell, Inc. Super-globuling for in vivo extended lifetimes
KR100710461B1 (ko) * 2005-10-12 2007-04-24 (주)씨에스이 소음기를 구비한 진공포장장치
WO2018094035A2 (en) * 2016-11-16 2018-05-24 Purdue Research Foundation Ligand ionophore conjugates

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832358A (en) * 1973-01-15 1974-08-27 Lilly Co Eli Deshydroxymethyl derivatives of monensin
FR2437213A1 (fr) * 1978-09-28 1980-04-25 Cm Ind Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation
US4431665A (en) * 1979-08-13 1984-02-14 Syntex (U.S.A.) Inc. Acylated laidlomycin derivatives
FR2463144A1 (fr) * 1979-08-13 1981-02-20 Syntex Inc Nouveaux diesters de laidlomycine, leur procede de production, compositions a usage veterinaire les contenant et leur utilisation pour accroitre le rendement d'assimilation des aliments chez un ruminant
JPS57106626A (en) * 1980-12-22 1982-07-02 Teijin Ltd Cytotoxic protein complex and its preparation
FR2498192A2 (fr) * 1981-01-22 1982-07-23 Pasteur Institut Nouveau compose polypeptidique thiole provenant d'un fragment de la toxine tetanique, son procede d'obtention et ses applications
FR2516794B1 (fr) * 1981-11-20 1985-10-25 Sanofi Sa Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique
FR2521010B1 (fr) * 1982-02-09 1985-07-19 Sanofi Sa Medicaments comportant en tant qu'association au moins une immunotoxine et au moins un ionophore carboxylique monovalent
FR2522968B1 (fr) * 1982-03-10 1986-03-28 Sanofi Sa Medicament cytotoxique forme de l'association d'a u moins une immunotoxine et de la chloroquine
JPS59116229A (ja) * 1982-12-24 1984-07-05 Teijin Ltd 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法
JPS59116232A (ja) * 1982-12-24 1984-07-05 Teijin Ltd 細胞毒性複合体及びその製造法
CA1214774A (en) * 1983-02-10 1986-12-02 Yusei Shiraga Benzodiazepine derivative
US4542027A (en) * 1984-02-23 1985-09-17 Syntex (U.S.A.) Inc. Laidlomycin phenylcarbamate
CA1314245C (en) * 1984-05-23 1993-03-09 Franz Jansen Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators

Also Published As

Publication number Publication date
IE58480B1 (en) 1993-09-22
IL75228A (en) 1990-06-10
EP0162781A1 (fr) 1985-11-27
ES543367A0 (es) 1986-01-16
US5144009A (en) 1992-09-01
ES8604228A1 (es) 1986-01-16
EP0162781B1 (fr) 1989-08-02
AU4279385A (en) 1985-11-28
US4919928A (en) 1990-04-24
NZ212118A (en) 1990-11-27
IL75228A0 (en) 1985-09-29
IE851279L (en) 1985-11-23
PT80501B (fr) 1986-12-16
GR851229B (da) 1985-11-25
CA1314245C (en) 1993-03-09
DK164457C (da) 1992-11-16
PT80501A (fr) 1985-06-01
DE3571928D1 (en) 1989-09-07
AU600651B2 (en) 1990-08-23
US4977280A (en) 1990-12-11
DK224785A (da) 1985-11-24
DK164457B (da) 1992-06-29

Similar Documents

Publication Publication Date Title
DK164596C (da) 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer, disse forbindelser til anvendelse til bekaempelse af sygdomme og deres anvendelse til fremstilling af et laegemiddel indeholdende dem
NO172972C (no) Fremgangsmaate for fremstilling av posestabler, innretningfor gjennomfoering av fremgangsmaaten og posestabel fremstilt ved fremgangsmaaten
DK534984D0 (da) Konjugater af makromolekylaere forbindelser og haemoglobin, fremgangsmaade til fremstilling deraf samt laegemiddel indeholdende dem
DK381985A (da) 3-pyridylforbindelser, deres fremstilling og anvendelse som laegemiddel
DK165922C (da) 1,2,3,6-tetrahydro-5-nitro-pyrimidinderivater, fremgangsmaade til deres fremstilling og deres anvendelse til bekaempelse af skadelige organismer
DK163517C (da) Fremgangsmaade til fremstilling af 4'-epidaunorubicin og 3',4'-diepidaunorubicin
DK457581A (da) 4,5-polymethylen-4-isothiazolin-3-oner fremgangsmaade til deres fremstilling og deres anvendelse
DK161989C (da) Fremgangsmaade til fremstilling af en forform til en sammensat hjelm, fremgangsmaade til fremstilling af en sammensat hjelm, forform til en sammensat hjelm, og sammensat hjelm
DK156579A (da) Oximino-triazolyl-ethaner deres fremstilling og anvendelse som fungicider
DK378479A (da) Fremgangsmaade til fremstilling af modoficerede alkydharpikser og harpiksernes anvendelse som lakbindemiddel
NO790934L (no) 2,6-dialkoksybenzamider og fremgangsmaate til deres fremstilling
DK163379A (da) Fremgangsmaade til fremstilling af substituerede 1,3-diaryl-2-imino-imidazolidiner og 2-imino-hexahydro-pyrimidiner
DK224785D0 (da) Konjugater, hvori en monovalent carboxylionophor ved hjaelp af en kovalent binding er knyttet til et makromolekyle, fremgangsmaade til fremstilling af konjugaterne og disses anvendelse som immunotoksinpotentiatorer
DK311989A (da) Fremgangsmaade til fremstilling af et hydraulisk bindemiddel
DK494381A (da) Veterinaer-praeparat og fremgangsmaade til fremstilling af et macrolid
DK99779A (da) Pentafluorbenzyloxycarbonylderivater deres fremstilling og anvendelse som insekticider og acaricider
DK94585A (da) Fiberblanding til forstaerkning af materialer, isaer til forstaerkning af hydrauliske bindemidler, blandingens anvendelse og formdele under anvendelse af blandingen
DK191679A (da) Substituerede alkanyl-azolyl-oximcarbamater samt fremgangsmaader til deres fremstilling og deres anvendelse som insecticider acaricider og nematodicider
NO790047L (no) Kompoundmaterialer og fremgangsmaate til deres fremstilling
DK21579A (da) 5-phenethyl-2-oxazolidon-derivater og fremgangsmaade til deres fremstilling
DK118879A (da) 2-hydroxymethyl-pyrazin-derivater og fremgangsmaade til deres fremstilling
DK36479A (da) 2,6-dinitrobenzenaminer deres fremstilling og anvendelse
DK370786D0 (da) Fremgangsmaade ved fremstilling af en forbindelse mellem to konstruktionselementer, og konstruktionselement
DK492785A (da) Fremgangsmaade til fremstilling af milbemycinderivater og forbindelser til anvendelse ved fremgangsmaaden
DK479379A (da) Bindemiddel og fremgangsmaade til fremstilling af foder i pelleteret form

Legal Events

Date Code Title Description
PBP Patent lapsed